AMPH vs GSK · P/E 12, rev $355.1M vs P/E 13, $103.31B cap
Amphastar P (AMPH) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported AMPH revenue for 2026-06-30 was $355.1M. Net income was $36.8M. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
GSK does not have a complete income-statement cache yet.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the AMPH and GSK stock pages for the full models.
Not investment advice.